Research Disclaimer
Impossible Dream Machine (“IDM”) is a research and intelligence organization focused on improving the understanding of ALS and supporting research, therapeutic development, biomarker strategy, and clinical-trial innovation.
Information presented on this website is provided for research, educational, and informational purposes only.
Research Is Not Medical Advice
Nothing on this website constitutes medical advice, diagnosis, treatment, or an individualized healthcare recommendation.
IDM does not provide medical care through this website.
People living with ALS, caregivers, and others seeking healthcare guidance should discuss medical decisions with appropriately qualified healthcare professionals familiar with their individual circumstances.
Do not delay or change medical care based solely on information presented on this website.
Research Findings May Be Preliminary
The website may discuss ongoing research, data analysis, hypotheses, emerging scientific findings, potential biomarkers, patient subgroups, progression patterns, treatment-response signals, artificial intelligence or machine-learning analyses, and other areas of scientific investigation.
Unless expressly stated otherwise, such information should be understood as research-stage information.
Research observations may:
- Be preliminary
- Require independent replication
- Change as additional data become available
- Depend on specific datasets or analytical methods
- Be affected by bias, missing data, measurement limitations, or other uncertainties
- Not have established clinical validity or utility
A research association or computational signal does not by itself establish causation, therapeutic effectiveness, or a clinically actionable finding.
Artificial Intelligence and Data Analysis
IDM may use statistical methods, machine learning, artificial intelligence, and other computational approaches to analyze complex data.
These technologies can identify patterns and generate hypotheses, but their outputs are subject to limitations in the underlying data, methods, assumptions, and validation processes.
Computational results require appropriate scientific interpretation and, where relevant, independent validation before being considered established findings.
No Representation of Therapeutic Benefit
References to therapies, drugs, biomarkers, clinical trials, biological mechanisms, patient subgroups, unusually slow or fast disease progression, long survival, stabilization, improvement, or other outcomes are not intended to imply that IDM has identified a cure or proven treatment for ALS.
Individual experiences and patient stories can inspire important research questions, but individual outcomes do not establish scientific or clinical proof.
Clinical Trials
Information about clinical trials is provided for general informational purposes only.
IDM does not determine through this website whether an individual should enroll in, discontinue, or modify participation in a clinical trial.
Eligibility, risks, benefits, and participation decisions should be discussed with the relevant trial investigators and healthcare professionals.
Third-Party Research
The website may reference research, datasets, publications, institutions, investigators, biotechnology companies, advocacy organizations, and other third parties.
References to third-party work do not necessarily indicate endorsement of every conclusion, product, therapy, or position associated with that party.
Third-party research remains subject to the limitations and context described by its original authors and publishers.
Our Commitment
IDM’s mission is ambitious, but our approach is grounded in scientific discipline.
We seek to distinguish clearly between:
- What we hope to discover.
- What the data suggest.
- What has been independently validated.
- And what is ready to inform real-world decisions.
That distinction is fundamental to our work.